OGNOrganon & Co.vs its industry peers
A metric-by-metric comparison of Organon & Co. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OGNEsta | $3.6B#8 | 17.8x#2 | 3.0x#4 | 0.6x#1 | -2.9%#7 | -78.4%#13 | 14.9%#1 | 15.7%#2 | 4.9%#2 | 5#1 | 111.7%#6 | 2.4%#1 |
| GPCR | $4.4B#1 | — | 3.2x#5 | — | — | -15.2%#8 | — | -10.4%#9 | — | — | -37.1%#15 | — |
| EWTX | $4.2B#2 | — | 9.3x#13 | — | — | -25.4%#10 | — | -0.0%#5 | -50.9%#7 | — | 112.7%#5 | — |
| ARQT | $4.1B#3 | 146.6x#4 | 18.4x#15 | 10.8x#3 | 91.3%#4 | 88.5%#1 | -3.3%#3 | -7.3%#6 | -4.1%#3 | — | 30.3%#8 | — |
| TNGX | $4.0B#4 | — | 3.9x#8 | 64.5x#7 | 48.3%#5 | 22.0%#6 | -178.4%#6 | -9.9%#7 | — | — | 197.6%#1 | — |
| LQDA | $3.8B#5 | 30.1x#3 | 19.3x#16 | 23.8x#5 | 1031.2%#2 | 47.1%#5 | -32.5%#4 | -35.3%#14 | — | — | 66.8%#7 | — |
| ABCL | $3.8B#6 | — | 4.2x#9 | 50.0x#6 | 160.6%#3 | 10.1%#7 | -289.0%#7 | -16.3%#11 | -28.0%#4 | — | 128.6%#2 | — |
| XENE | $3.8B#7 | — | 3.0x#3 | 500.3x#8 | — | -47.6%#12 | -4974.3%#8 | -27.8%#12 | -32.5%#5 | — | -5.7%#11 | — |
| PBLS | $3.6B#9 | — | 3.4x#6 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ACAD | $3.6B#10 | 9.3x#1 | 2.7x#1 | 3.3x#2 | 11.9%#6 | 73.0%#2 | 9.8%#2 | 29.9%#1 | 11.4%#1 | — | -7.3%#12 | — |
| VKTX | $3.4B#11 | — | 5.8x#12 | — | — | -227.1%#15 | — | -61.1%#16 | — | — | -26.0%#14 | — |
| DYN | $3.4B#12 | — | 4.8x#10 | — | — | -40.6%#11 | — | -0.0%#4 | -1301.5%#8 | — | -25.0%#13 | — |
| ELVN | $3.3B#13 | — | 3.7x#7 | — | — | -16.5%#9 | — | -11.6%#10 | — | — | 126.2%#3 | — |
| AMLX | $3.3B#14 | — | 13.7x#14 | — | -100.0%#8 | 52.0%#4 | — | -60.5%#15 | — | — | 115.9%#4 | — |
| IRON | $3.1B#15 | — | 4.8x#11 | — | — | -94.0%#14 | — | -32.9%#13 | -39.0%#6 | — | -4.0%#10 | — |
| IDYA | $3.1B#16 | — | 2.8x#2 | 14.0x#4 | 3024.4%#1 | 58.6%#3 | -72.8%#5 | -10.4%#8 | — | — | 1.2%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice